These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 10554162

  • 1. Synthesis of Bcl-2 in response to anthracycline treatment may contribute to an apoptosis-resistant phenotype in leukemic cell lines.
    Durrieu F, Belaud-Rotureau MA, Lacombe F, Dumain P, Reiffers J, Boisseau MR, Bernard P, Belloc F.
    Cytometry; 1999 Jun 01; 36(2):140-9. PubMed ID: 10554162
    [Abstract] [Full Text] [Related]

  • 2. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V, Stötzer O, Gullis E, Pelka-Fleischer R, Pogrebniak A, Gieseler F, Wilmanns W.
    Leukemia; 1999 Nov 01; 13(11):1864-72. PubMed ID: 10557064
    [Abstract] [Full Text] [Related]

  • 3. The role of BCL-2 and bax protein in monocyte-mediated apoptosis in human leukemic cell lines.
    Legdeur MC, Bontje PM, Ossenkoppele GJ, Beelen RH, van de Loosdrecht AA, Broekhoven MG, Langenhuijsen MM, Thijsen SF, Hofstee H, Schuurhuis GJ.
    Exp Hematol; 1996 Nov 01; 24(13):1530-9. PubMed ID: 8950237
    [Abstract] [Full Text] [Related]

  • 4. A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia.
    van Stijn A, Kok A, van der Pol MA, Feller N, Roemen GM, Westra AH, Ossenkoppele GJ, Schuurhuis GJ.
    Leukemia; 2003 Apr 01; 17(4):780-6. PubMed ID: 12682637
    [Abstract] [Full Text] [Related]

  • 5. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y, Ibrado AM, Reed JC, Bullock G, Ray S, Tang C, Bhalla K.
    Leukemia; 1997 Feb 01; 11(2):253-7. PubMed ID: 9009089
    [Abstract] [Full Text] [Related]

  • 6. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.
    Anticancer Res; 2002 Feb 01; 22(3):1361-8. PubMed ID: 12168812
    [Abstract] [Full Text] [Related]

  • 7. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.
    Cheng Z, Yang N, Liang W, Yan X, Li L, Pan L.
    Leuk Lymphoma; 2012 Jul 01; 53(7):1383-9. PubMed ID: 22185283
    [Abstract] [Full Text] [Related]

  • 8. Modulation of idarubicin-induced apoptosis in human acute myeloid leukemia blasts by all-trans retinoic acid, 1,25(OH)2 vitamin D3, and granulocyte-macrophage colony-stimulating factor.
    Ketley NJ, Allen PD, Kelsey SM, Newland AC.
    Blood; 1997 Dec 01; 90(11):4578-87. PubMed ID: 9373269
    [Abstract] [Full Text] [Related]

  • 9. Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.
    Kasimir-Bauer S, Beelen D, Flasshove M, Noppeney R, Seeber S, Scheulen ME.
    Exp Hematol; 2002 Nov 01; 30(11):1302-8. PubMed ID: 12423683
    [Abstract] [Full Text] [Related]

  • 10. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
    Lopes EC, Garcia M, Benavides F, Shen J, Conti CJ, Alvarez E, Hajos SE.
    Leuk Res; 2003 May 01; 27(5):413-23. PubMed ID: 12620293
    [Abstract] [Full Text] [Related]

  • 11. Modulation of resistance to idarubicin by the cyclosporin PSC 833 (valspodar) in multidrug-resistant cells.
    Lacayo NJ, Duran GE, Sikic BI.
    J Exp Ther Oncol; 2003 May 01; 3(3):127-35. PubMed ID: 14641819
    [Abstract] [Full Text] [Related]

  • 12. Expression of bcl-2 and bax in TGF-beta 1-induced apoptosis of L1210 leukemic cells.
    Motyl T, Grzelkowska K, Zimowska W, Skierski J, Wareski P, Płoszaj T, Trzeciak L.
    Eur J Cell Biol; 1998 Apr 01; 75(4):367-74. PubMed ID: 9628323
    [Abstract] [Full Text] [Related]

  • 13. Influence of Bcl-2 overexpression on the ceramide pathway in daunorubicin-induced apoptosis of leukemic cells.
    Allouche M, Bettaieb A, Vindis C, Rousse A, Grignon C, Laurent G.
    Oncogene; 1997 Apr 17; 14(15):1837-45. PubMed ID: 9150390
    [Abstract] [Full Text] [Related]

  • 14. Study of apoptosis-related responses of leukemic blast cells to in vitro anthracycline treatment.
    Belaud-Rotureau MA, Durrieu F, Labroille G, Lacombe F, Fitoussi O, Agape P, Marit G, Reiffers J, Belloc F.
    Leukemia; 2000 Jul 17; 14(7):1266-75. PubMed ID: 10914552
    [Abstract] [Full Text] [Related]

  • 15. Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.
    Campone M, Vavasseur F, Le Cabellec MT, Meflah K, Vallette FM, Oliver L.
    Leukemia; 2001 Sep 17; 15(9):1377-87. PubMed ID: 11516098
    [Abstract] [Full Text] [Related]

  • 16. Comparison of idarubicin and daunorubicin regarding intracellular uptake, induction of apoptosis, and resistance.
    Lotfi K, Zackrisson AL, Peterson C.
    Cancer Lett; 2002 Apr 25; 178(2):141-9. PubMed ID: 11867198
    [Abstract] [Full Text] [Related]

  • 17. Beta-hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1).
    Masuda Y, Nishida A, Hori K, Hirabayashi T, Kajimoto S, Nakajo S, Kondo T, Asaka M, Nakaya K.
    Oncogene; 2003 Feb 20; 22(7):1012-23. PubMed ID: 12592388
    [Abstract] [Full Text] [Related]

  • 18. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec 20; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 19. Reduced expression of Bax in ceramide-resistant HL-60 subline.
    Sawai H, Kawai S, Domae N.
    Biochem Biophys Res Commun; 2004 Jun 18; 319(1):46-9. PubMed ID: 15158440
    [Abstract] [Full Text] [Related]

  • 20. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
    Kim KM, Lee K, Hong YS, Park HY.
    Exp Mol Med; 2000 Dec 31; 32(4):246-54. PubMed ID: 11190279
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.